パッチドは触媒的に作用し,スムートヘッドの活動を抑制します
J Taipale1, M K Cooper, T Maiti
1Howard Hughes Medical Institute, Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Nature
|August 23, 2002
まとめ
パッチド (Ptc) タンパク質は,間接的にスムージド (Smo) を阻害することによってヘッジホッグ (Hh) 経路の活動を抑制します. Ptcは分子トランスポーターとして機能し,発育とがんにおける経路レベルを調節するために重要です.
科学分野:
- 分子生物学は分子生物学である.
- 発達生物学 発達生物学について
- がん研究 がん研究
背景:
- パッチド (Ptc) とスムージド (Smo) の変異は,ヘッジホッグ (Hh) 信号経路を活性化します.
- Hh経路の失調は,基礎細胞癌 (BCC) や髄芽細胞腫などのヒトがんと関連しています.
- SmoのPtc調節の正確なメカニズムは,遺伝的証拠にもかかわらず,不明のままです.
研究 の 目的:
- パッチド (Ptc) がスムージド (Smo) の活動を調節するメカニズムを解明する.
- Hhシグナル伝達におけるPtcとSmoの機能的関係を調査する.
- Ptcのトランスメブラントランスポーターのような構造が,その機能における役割を決定する.
主な方法:
- Hh反応性細胞におけるPtcとSmoの物理的関連性を評価した.
- 結合していないPtcがSmo活動に与える影響を定量化した.
- 機能的影響を評価するために,バクテリアトランスポーターと同型であるPtc内の保存された残留物の変異.
主要な成果:
- パッチド (Ptc) とスムージド (Smo) は,Hh反応性細胞内で有意に結合しない.
- 自由Ptc (Hhに結合していない) は,Smo活動をサブステキオメトリック的に抑制し,経路レベルを制御します.
- バクテリアのトランスポーター機能と同様のPtcの保存された残留物を変化させると,Ptcの腫瘍抑制活性が低下する.
結論:
- パッチド (Ptc) は,間接的にスムージド (Smo) 活動を抑制する機能を持ち,おそらくは,トランスメブラン分子トランスポーターメカニズムを介して作用する.
- トランスポーターとしてのPtcの役割は,Hh経路の活性レベルを調節するために重要です.
- このメカニズムは,小さな分子の分布または濃度を調節することによって潜在的に媒介されます.
関連する概念動画
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:33Hedgehog Signaling Pathway
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...